The value of FDG-PET in patients with painful total knee arthroplasty

Eur J Nucl Med Mol Imaging. 2006 Oct;33(10):1218-25. doi: 10.1007/s00259-006-0127-1. Epub 2006 May 24.

Abstract

Purpose: The purpose of this study was to evaluate 18F-fluorodeoxyglucose (FDG) uptake in patients with painful total knee arthroplasty and to relate FDG uptake to the location of soft tissue pain.

Methods: Twenty-eight patients with painful total knee arthroplasty had a clinical examination, standard radiographs, CT measurement of rotation of the femoral component and FDG-PET (18 PET/CT, 10 PET). The diagnosis of infection was based on microbiological examinations of surgical specimens (n=12) or clinical follow-up for at least 6 months (n=16), 99mTc-labelled monoclonal antibody scintigraphy and joint aspiration.

Results: Twenty-seven of 28 patients presented with diffuse synovial FDG uptake. Additional focal extrasynovial FDG uptake was observed in 19 knees. Twenty-four of the 28 patients had a diagnosis of internal femoral malrotation. The remaining four patients showed no rotation (0 degrees) and 3 degrees, 4 degrees and 7 degrees of external rotation, respectively. Three patients presented with the additional diagnosis of an infected total knee replacement. Pain was described as diffuse (n=10) or focal (n=18). In two knees a relationship between pain location and FDG uptake was observed. Of ten patients with a severe internal femoral component rotation (>6 degrees), seven had focal uptake, four in the femoral periosteum and three in the tibial periosteum. The difference between knees with severe malrotation and the remaining knees was not significant (p=1.000, Fisher's Exact Test).

Conclusion: Diffuse synovial and focal extrasynovial FDG-PET uptake is commonly found in patients with malrotation of the femoral component and is not related to pain location. The information provided by FDG-PET does not contribute to the diagnosis and management of individual patients with persistent pain after total knee replacement.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Arthralgia / diagnostic imaging*
  • Arthralgia / etiology
  • Arthroplasty, Replacement, Knee / adverse effects*
  • Female
  • Fluorodeoxyglucose F18*
  • Humans
  • Joint Instability / diagnostic imaging*
  • Joint Instability / etiology
  • Knee Joint / diagnostic imaging*
  • Male
  • Middle Aged
  • Positron-Emission Tomography / methods*
  • Prosthesis Failure
  • Prosthesis-Related Infections / diagnostic imaging*
  • Prosthesis-Related Infections / etiology
  • Radiopharmaceuticals
  • Treatment Outcome

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18